#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary immunodeficiency syndrome Rhabdomyosarcoma recurrent Neuronal ceroid lipofuscinosis Lung adenocarcinoma Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Optic glioma Ischaemic stroke Pulmonary alveolar haemorrhage Cystic fibrosis gastrointestinal disease Superficial vein thrombosis Renal cell carcinoma Uterine leiomyosarcoma Undifferentiated sarcoma Myelodysplastic syndrome with excess blasts Marginal zone lymphoma recurrent More trials…

    Learn about Rare Diseases

    Congenital generalised lipodystrophy – Life with Disease Congenital nephrogenic diabetes insipidus – Treatment Skin angiosarcoma – Treatment Mastocytosis – Treatment Nephrotic syndrome – Treatment Nephroblastoma – Treatment Idiopathic pulmonary fibrosis – Basic Information Ewing’s sarcoma recurrent – Basic Information Methylmalonic acidaemia – Life with Disease Lennox-Gastaut syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Chloride Ion Arachis Hypogaea (762) Phenylalanine Nicotine Resinate LYSERGIDE Ravulizumab Alendronic Acid Binimetinib Elvn-002-1 TEDUGLUTIDE Lumasiran Bi 764524 Insulin Glargine Alitretinoin Crofelemer Siponimod Fumaric Acid Semaglutide Oxycodone Hydrochloride Montelukast Histamine Hydrochloride More therapies…

    Learn about Your Condition

    Polycythaemia vera Neuromyopathy Osteosarcoma Coronary artery bypass Spermatocele Arterial stiffness Benign neoplasm of ureter Plasma cell myeloma Propionic acidaemia Hereditary angioedema Pulmonary embolism Giant cell arteritis Altered state of consciousness Thyroid cancer Alagille syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Glomerulonephritis

  • Study of Desmopressin for Prevention of Bleeding After Kidney Biopsy in Patients with Rare Glomerulonephritis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • DESMOPRESSIN ACETATE
    Poland

  • Study on the Safety and Effects of OMS906 for Patients with C3 Glomerulopathy and Idiopathic Immune Complex-Mediated Glomerulonephritis

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Oms906
    Lithuania Poland

  • Study on the Effects of Belimumab and Rituximab for Patients with Severe Systemic Lupus Erythematosus

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Glomerulonephritis
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Belimumab
    • Rituximab
    The Netherlands

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!